Nature of the Business - Additional Information (Details) $ / shares in Units, $ in Thousands				1 Months Ended	3 Months Ended
	Dec. 16, 2022 shares	Dec. 14, 2022 USD ($)	Nov. 17, 2022 USD ($) $ / shares shares	Dec. 16, 2022 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($) shares	Dec. 31, 2022 USD ($)	Nov. 18, 2022 shares	Dec. 31, 2021 shares
Organization Consolidation Presentation Of Financial Statements [Line Items]
Reverse stock split conversion ratio			0.406
Aggregate net proceeds from concurrent private placement			$ 4,700
Net loss					$ 12,756	$ 7,220
Accumulated deficit					68,788		$ 56,032
Cash, cash equivalents and investments					$ 159,500
Convertible Preferred Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Convertible preferred stock outstanding | shares						27,471,911		0	27,471,911
Initial Public Offering
Organization Consolidation Presentation Of Financial Statements [Line Items]
Initial public offering price per share | $ / shares			$ 12.50
Description of reverse stock spilt					In connection with the IPO, the Company effected a 1-for-2.466 reverse stock split of the Company’s common stock and adjusted the ratio at which the Company’s preferred stock is convertible into common stock, the number of shares available for issuance under the 2019 Stock Incentive Plan (“2019 Plan”) and the number of options and exercise prices of options granted under the 2019 Plan as a result of the 1-for-2.466 reverse stock split.
Initial Public Offering | Common Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Issuance of common stock | shares			7,550,000
Proceeds from Issuance Initial Public Offering			$ 94,400
Initial Public Offering | Common Stock | Convertible Preferred Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Convertible preferred stock converted into common stock shares | shares			11,140,262
Concurrent Private Placement
Organization Consolidation Presentation Of Financial Statements [Line Items]
Initial public offering price per share | $ / shares			$ 12.50
Concurrent Private Placement | Common Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Issuance of common stock | shares			400,000
Underwriters
Organization Consolidation Presentation Of Financial Statements [Line Items]
Issuance of common stock | shares	1,035,540
Gross proceeds from exercise of option		$ 12,900
Underwriters | Common Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Underwriters option to purchase common stock | shares			1,132,500
IPO and Option Exercise
Organization Consolidation Presentation Of Financial Statements [Line Items]
Aggregate net proceeds received from IPO and option exercise		99,800
Payment of underwriting discounts and commissions				$ 7,500
Offering expenses payable		$ 3,600